Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $344.34 -1.07%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Evercore ISI analyst Josh Schimmer reiterated an Outperform rating and $168.00 price target on Krystal Biotech (NASDAQ: KRYS)
- Removes from Tactical Outperform List.
For an analyst ratings summary and ratings history on Krystal Biotech click here. For more ratings news on Krystal Biotech click here.
Shares of Krystal Biotech closed at $111.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR) Following Sector Deal
- Kroger (KR) PT Lowered to $63 at UBS as Execution Challenges Persist
- Devon Energy (DVN) PT Lowered to $67 at Wolfe Research: Activist Toms interest positive
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsRelated Entities
Evercore Tactical Outperform ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
